Understanding and meeting injection device needs in multiple sclerosis: a survey of patient attitudes and practices
Elisabetta Verdun di Cantogno1, Susan Russell2, Tom Snow21Global Clinical Development Unit, Merck Serono S.A. – Geneva, Switzerland; 2Global Marketing, Merck Serono S.A. – Geneva, SwitzerlandBackground: All established disease-modifying drugs for multiple sclerosis requir...
Main Authors: | Russell S, Verdun di Cantogno E, Snow T |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-03-01
|
Series: | Patient Preference and Adherence |
Online Access: | http://www.dovepress.com/understanding-and-meeting-injection-device-needs-in-multiple-sclerosis-a6863 |
Similar Items
-
A systematic review of relapse rates during pregnancy and postpartum in patients with relapsing multiple sclerosis
by: Kerstin Hellwig, et al.
Published: (2021-11-01) -
Patient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb study
by: Verdun di Cantogno Elisabetta, et al.
Published: (2010-04-01) -
Understanding and meeting the needs of those using growth hormone injection devices
by: Parker Dorothy, et al.
Published: (2006-10-01) -
Preferences and Perspectives of Specialist Multiple Sclerosis Nurses and Patients with Multiple Sclerosis Regarding the New RebiSmart® 3.0 Autoinjector versus Other Assistive Devices
by: Colten SS, et al.
Published: (2024-02-01) -
The MS Choices Survey: findings of a study assessing physician and patient perspectives on living with and managing multiple sclerosis
by: Riñon A, et al.
Published: (2011-12-01)